Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Payables (2016 - 2025)

Conmed's Payables history spans 16 years, with the latest figure at $93.6 million for Q4 2025.

  • For Q4 2025, Payables fell 8.41% year-over-year to $93.6 million; the TTM value through Dec 2025 reached $93.6 million, down 8.41%, while the annual FY2025 figure was $93.6 million, 8.41% down from the prior year.
  • Payables reached $93.6 million in Q4 2025 per CNMD's latest filing, down from $107.1 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $107.1 million in Q3 2025 to a low of $46.6 million in Q3 2021.
  • Average Payables over 5 years is $81.9 million, with a median of $80.2 million recorded in 2023.
  • Peak YoY movement for Payables: dropped 18.53% in 2021, then soared 59.3% in 2022.
  • A 5-year view of Payables shows it stood at $58.2 million in 2021, then increased by 26.11% to $73.4 million in 2022, then increased by 20.21% to $88.2 million in 2023, then rose by 15.9% to $102.2 million in 2024, then decreased by 8.41% to $93.6 million in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Payables are $93.6 million (Q4 2025), $107.1 million (Q3 2025), and $101.1 million (Q2 2025).